Victoria L. Brown Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Victoria L. Brown is Program Team Lead of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 23,556 shares of APLS, which is worth approximately $645,669. The most recent transaction as insider was on Jan 20, 2023, when has been sold 1,412 shares (Common Stock) at a price of $52.05 per share, resulting in proceeds of $73,494. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.6K

0% 3M change

0% 12M change

Total Value Held $645,669

Victoria L. Brown Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 20 2023	SELL Payment of exercise price or tax liability	$73,494 $52.05 p/Share	1,412 Reduced 5.66%	23,556 Common Stock
Oct 26 2022	SELL Payment of exercise price or tax liability	$7,593 $58.41 p/Share	130 Reduced 0.52%	24,844 Common Stock
Jun 17 2022	SELL Open market or private sale	$121,410 $45.0 p/Share	2,698 Reduced 9.75%	24,974 Common Stock
Mar 25 2022	SELL Payment of exercise price or tax liability	$4,041 $49.28 p/Share	82 Reduced 0.29%	28,325 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$8,246 $47.12 p/Share	175 Reduced 0.61%	28,407 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$16,748 $38.59 p/Share	434 Reduced 1.5%	28,582 Common Stock
Jan 21 2022	BUY Grant, award, or other acquisition	-	17,466 Added 37.58%	29,016 Common Stock
Oct 26 2021	BUY Grant, award, or other acquisition	-	882 Added 7.17%	11,422 Common Stock
Mar 25 2021	SELL Payment of exercise price or tax liability	$3,375 $41.16 p/Share	82 Reduced 0.82%	9,952 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	1,250 Added 11.08%	10,034 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$6,872 $47.72 p/Share	144 Reduced 1.61%	8,784 Common Stock
Jan 28 2021	BUY Grant, award, or other acquisition	-	5,000 Added 35.9%	8,928 Common Stock
Oct 07 2020	SELL Open market or private sale	$420,000 $35.0 p/Share	12,000 Reduced 76.89%	3,607 Common Stock
Oct 07 2020	BUY Exercise of conversion of derivative security	$227,760 $18.98 p/Share	12,000 Added 43.47%	15,607 Common Stock

VLB

Victoria L. Brown

Program Team Lead

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account